Warsaw plans ‘Drug Policy 2.0’ to cut 1200-day wait for new medicines
Poland is initiating its “Drug Policy 2.0” reform to address a record-high 1,211-day delay in access to new medicines, despite maintaining regional leadership in oncology. The latest Access GAP...

